Arch Oncology's Series B Round

Arch Oncology raised a round of funding on March 25, 2019.

Arch Oncology is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer.…

Articles about Arch Oncology's Series B Round: